PUBLISHER: The Business Research Company | PRODUCT CODE: 1948374
PUBLISHER: The Business Research Company | PRODUCT CODE: 1948374
An ultracentrifuge is a high-speed centrifuge capable of separating particles according to size, density, and shape by spinning samples at extremely high rotational speeds, often exceeding 100,000 RPM. It is mainly used to isolate and purify biological molecules such as proteins, nucleic acids, and viruses at the molecular level.
The primary types of ultracentrifuges include desktop centrifuges and floor centrifuges. Desktop centrifuges are compact, bench-top laboratory devices designed for high-speed sample separation, making them suitable for small-scale operations and environments with limited space. These centrifuges are used in applications such as molecular biology, biochemistry, and polymer science and are utilized by end users including hospitals, biotechnology and pharmaceutical companies, and academic and research institutions.
Tariffs are impacting the ultracentrifuge market by increasing costs of imported high-precision components like rotors, vacuum systems, and electronic controls. Asia-Pacific regions, including China and India, are most affected due to reliance on imported ultracentrifuge equipment. Despite the increased costs, tariffs have encouraged local manufacturing and assembly of centrifuges, enabling regional suppliers to expand their presence.
The ultracentrifuge market research report is one of a series of new reports from The Business Research Company that provides ultracentrifuge market statistics, including ultracentrifuge industry global market size, regional shares, competitors with a ultracentrifuge market share, detailed ultracentrifuge market segments, market trends and opportunities, and any further data you may need to thrive in the ultracentrifuge industry. This ultracentrifuge market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The ultracentrifuge market size has grown rapidly in recent years. It will grow from $1.42 billion in 2025 to $1.58 billion in 2026 at a compound annual growth rate (CAGR) of 10.9%. The growth in the historic period can be attributed to advancements in molecular biology research, increasing protein and nucleic acid studies, growth of biotechnology labs, demand for virus isolation techniques, expansion of academic research centers.
The ultracentrifuge market size is expected to see rapid growth in the next few years. It will grow to $2.36 billion in 2030 at a compound annual growth rate (CAGR) of 10.5%. The growth in the forecast period can be attributed to rising adoption in precision medicine research, integration with lab automation systems, increasing demand for high-throughput centrifugation, growth in biopharmaceutical production, expansion in polymer and material science applications. Major trends in the forecast period include high-speed molecular separation, automated sample handling, multi-application centrifuge platforms, ai-enhanced protocol optimization, remote monitoring and control.
The increasing prevalence of infectious diseases is increasingly supporting the expansion of the ultracentrifuge market going forward. Infectious diseases are caused by microorganisms such as bacteria, viruses, fungi, or parasites and can spread through direct contact, contaminated food or water, or insect vectors, often requiring treatments such as antibiotics or antivirals. The rising prevalence of infectious diseases is influenced by factors including climate change, global travel, urbanization, and inadequate sanitation. Ultracentrifuges play a vital role in infectious disease research and control by separating and purifying viral pathogens, supporting accurate diagnosis and epidemiological surveillance, and concentrating viral or bacterial components for vaccine development. For example, in March 2024, according to the Centers for Disease Control and Prevention, a US-based public health agency, reported cases increased from 8,320 in 2022 to 9,615 in 2023, with incidence rates rising from 2.5 to 2.9 per 100,000 people. Consequently, the growing prevalence of infectious diseases is reinforcing demand for ultracentrifuge systems.
The growing demand for personalized medicine is expected to propel the growth of the ultracentrifuge market going forward. Personalized medicine is a healthcare approach that tailors treatments based on individual patient characteristics. Demand for personalized medicine is increasing due to advances in genomic technologies that enable precise identification of genetic variations and targeted therapies. Ultracentrifuges support personalized medicine by enabling accurate separation and analysis of biomolecules, including proteins, nucleic acids, and extracellular vesicles. For example, in February 2024, according to the Personalized Medicine Coalition, the U.S. Food and Drug Administration approved 26 new personalized medicines in 2023, compared with 12 approvals in 2022. Therefore, rising demand for personalized medicine is driving ultracentrifuge market growth.
Major companies operating in the ultracentrifugation market are concentrating on the development of advanced solutions such as automated gradient preparation to improve throughput and reproducibility. Automated gradient preparation involves the use of automated systems to create precise density gradients in centrifuge tubes, reducing manual handling and ensuring sample consistency. For instance, in April 2025, Beckman Coulter Life Sciences, a US-based provider of laboratory automation and diagnostic systems, launched the OptiMATE Gradient Maker to accelerate density gradient ultracentrifugation workflows. The system reduces gradient preparation and centrifugation times, shortening spin cycles from up to 48 hours to less than five hours while minimizing manual steps such as sealing and method configuration. Its plug-and-play design integrates with existing laboratory infrastructure and delivers consistent gradients for high-purity viral vector purification applications such as AAV. The intuitive software enables rapid operator training, allowing laboratories to enhance efficiency and reproducibility in ultracentrifuge workflows.
Major companies operating in the ultracentrifuge market are Beckman Coulter Inc., Thermo Fisher Scientific Inc., Eppendorf AG, Sartorius AG, KUBOTA Corporation, Hettich Instruments, Sigma Laborzentrifugen GmbH, Hitachi Koki Co Ltd, Haier Biomedical, Hunan Xiangyi Laboratory Instrument Development, OHAUS Corporation, BIOBASE Co Ltd, DLAB Scientific, Hanil Scientific Inc., NuAire Inc., QIAGEN N V, Oxford Lab Products, Bio Rad Laboratories Inc., Labnet International Inc., Porter Rayward Scientific, Sichuan Shuke Instruments, Dalong Instruments, Hunan Anjunyan Instruments, Xiangyi Group, LW Scientific, Boekel Scientific, IKA Werke GmbH & Co KG
North America was the largest region in the ultracentrifuge market in 2025. The regions covered in the ultracentrifuge market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the ultracentrifuge market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The ultracentrifuge market consists of sales of rotors, centrifuge chambers, control panels, sample tubes, and holders. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Ultracentrifuge Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses ultracentrifuge market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for ultracentrifuge ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The ultracentrifuge market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.